Suppr超能文献

NPC1L1在人肠道胆固醇吸收中的定位及作用

Localization and role of NPC1L1 in cholesterol absorption in human intestine.

作者信息

Sané Alain Théophile, Sinnett Daniel, Delvin Edgard, Bendayan Moise, Marcil Valérie, Ménard Daniel, Beaulieu Jean-François, Levy Emile

机构信息

Department of Nutrition, CHU-Sainte-Justine, University of Montreal, Montreal, Quebec H3T 1C5, Canada.

出版信息

J Lipid Res. 2006 Oct;47(10):2112-20. doi: 10.1194/jlr.M600174-JLR200. Epub 2006 Jul 7.

Abstract

Recent studies have documented the presence of Niemann-Pick C1-Like 1 (NPC1L1) in the small intestine and its capacity to transport cholesterol in mice and rats. The current investigation was undertaken to explore the localization and function of NPC1L1 in human enterocytes. Cell fractionation experiments revealed an NPC1L1 association with apical membrane of the enterocyte in human jejunum. Signal was also detected in lysosomes, endosomes, and mitochondria. Confirmation of cellular NPC1L1 distribution was obtained by immunocytochemistry. Knockdown of NPC1L1 caused a decline in the ability of Caco-2 cells to capture micellar [(14)C]free cholesterol. Furthermore, this NPC1L1 suppression resulted in increased and decreased mRNA levels and activity of HMG-CoA reductase, the rate-limiting step in cholesterol synthesis, and of ACAT, the key enzyme in cholesterol esterification, respectively. An increase was also noted in the transcriptional factor sterol-regulatory element binding protein that modulates cholesterol homeostasis. Efforts were devoted to define the impact of NPC1L1 knockdown on other mediators of cholesterol uptake. RT-PCR evidence is presented to show the significant decrease in the levels of scavenger receptor class B type I (SR-BI) with no changes in ABCA1, ABCG5, and cluster determinant 36 in NPC1L1-deficient Caco-2 cells. Together, our data suggest that NPC1L1 contributes to intestinal cholesterol homeostasis and possibly cooperates with SR-BI to mediate cholesterol absorption in humans.

摘要

最近的研究已证明,尼曼-皮克C1样1蛋白(NPC1L1)存在于小肠中,并且在小鼠和大鼠体内具有运输胆固醇的能力。目前的研究旨在探索NPC1L1在人肠细胞中的定位和功能。细胞分级分离实验显示,NPC1L1与人空肠肠细胞的顶端膜相关联。在溶酶体、内体和线粒体中也检测到了信号。通过免疫细胞化学证实了细胞内NPC1L1的分布。敲低NPC1L1会导致Caco-2细胞摄取胶束状[(14)C]游离胆固醇的能力下降。此外,这种对NPC1L1的抑制分别导致胆固醇合成限速步骤中3-羟基-3-甲基戊二酰辅酶A还原酶(HMG-CoA还原酶)的mRNA水平和活性增加,以及胆固醇酯化关键酶酰基辅酶A胆固醇酰基转移酶(ACAT)的mRNA水平和活性降低。还注意到调节胆固醇稳态的转录因子固醇调节元件结合蛋白增加。研究致力于确定敲低NPC1L1对其他胆固醇摄取介质的影响。逆转录聚合酶链反应(RT-PCR)证据表明,在缺乏NPC1L1的Caco-2细胞中,B类I型清道夫受体(SR-BI)水平显著降低,而ATP结合盒转运蛋白A1(ABCA1)、ATP结合盒转运蛋白G5(ABCG5)和簇决定簇36(CD36)没有变化。总之,我们的数据表明,NPC1L1有助于肠道胆固醇稳态,并且可能与SR-BI协同作用以介导人类的胆固醇吸收。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验